Italy’s Medicines Agency AIFA Welcomes New Leadership for Scientific and Economic Commission
The Italian Medicines Agency (AIFA) has announced the appointment of Lara Nicoletta Angela Gitto as the new president of the Scientific and Economic Commission (CSE). The Minister of Health, Orazio Schillaci, signed the decree appointing Gitto, who hails from Milazzo and brings a wealth of experience to the role.
Gitto, aged 50, holds a degree in Law from the University of Messina and a master’s degree in Health Economics. She is currently an associate professor in the Department of Economics at the University of Messina. Her expertise in the field makes her a suitable candidate to lead the new commission, which will replace the Technical-Scientific Commission (CTS) and the Prices and Reimbursement Committee (CPR) of AIFA.
In addition to Gitto, the new commission will also include experts such as Giancarlo Agnelli, Walter Marrocco, Vincenzo Danilo Lozupone, Ida Fortino, Elisa Sangiorgi, Giuseppe Toffoli, and Giovanna Scroccaro. These individuals have been designated by the Minister of Health and the Permanent Conference for relations between the State, the regions, and the autonomous provinces of Trento and Bolzano.
The decree specifies that the technical-scientific director of AIFA and the president of the Higher Institute of Health, or their delegate, will also be ex-officio members of the commission. Each non-legal member of the commission will serve a three-year term and is entitled to a gross annual allowance of €25,000.
The new AIFA scientific and economic drug commission is a fundamental part of the agency’s ongoing reform efforts. The appointed members will play a crucial role in shaping the future of drug regulation and pricing in Italy.
This announcement comes as a positive development for the Italian healthcare system, and the new commission is expected to bring fresh perspectives and expertise to the table. Gitto’s leadership, in particular, is anticipated to steer the commission towards achieving its goals effectively.